Accencio: See IP Differently

Accencio operates at the intersection of molecular science and intellectual property, providing innovative solutions for pharmaceutical research and development. The company leverages its proprietary molecular landscaping technology to identify clinical stage molecules that can be repurposed for new treatments, particularly in the fight against diseases like COVID-19. Accencio serves pharmaceutical companies, research institutions, and biotech firms, offering them the tools and intelligence needed to accelerate drug discovery and development. The business model is based on providing detailed molecular and IP analysis, which clients can use to guide their research and development efforts. Revenue is generated through service fees and collaborative research agreements.

Keywords: molecular science, intellectual property, drug discovery, pharmaceutical research, biotech, COVID-19, molecular landscaping, clinical stage molecules, repurposing, innovation.